Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin

Eur J Dermatol. 2019 Apr 1;29(2):218-220. doi: 10.1684/ejd.2019.3502.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acitretin / therapeutic use*
  • Adalimumab / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Humans
  • Keratolytic Agents / therapeutic use*
  • Middle Aged
  • Pityriasis Rubra Pilaris / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Keratolytic Agents
  • Tumor Necrosis Factor-alpha
  • ixekizumab
  • Adalimumab
  • Acitretin